Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Innate Immunity in Ozone-induced Airway Inflammation in COPD

NCT04669743 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT04669743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04669743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Innate Immunity in Ozone-induced Airway Inflammation in COPD
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 7, 2016
Completion date
December 31, 2030
Enrollment
72 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

airway disease, copd exacerbation, pollution related respiratory disorder, pollution; exposure, pulmonary disease, chronic obstructive